Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
KBH / KB Home 8-K (Current Report)

23h sec.gov
Document UNITED STATES
KBH

57
Making A Down Payment On Lennar

2018-07-16 seekingalpha
Capital intensity, cyclicality and cost (inflation) sensitivity render homebuilders unfriendly to investors, but at least they know the risks.
TMHC FB TOL KBH LEN KR AMZN INST SBUX APR AET APRLY

14
Top Analyst Reports for PepsiCo, Eli Lilly & Broadcom

2018-07-13 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PepsiCo (PEP), Eli Lilly (LLY) and Broadcom (AVGO). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
LMT KBH PEP BIIB UNP AVGO MPC

5
KBH / KB Home 10-Q (Quarterly Report)

2018-07-06 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
KBH

5
Why I Still Favor Real Estate And Homebuilders

2018-07-03 seekingalpha
Private sector, residential and single-family construction gains offer solid evidence of a healthy environment for housing and homebuilders’ shares.
HD KBH PHM

34
5 Broker-Friendly Stocks to Brave Escalating Trade War Fears

2018-07-03 zacks
The possibility of an all-out trade war between the world’s two biggest economies — United States and China — has resulted in markets being volatile of late. President Trump imposed steep tariffs on China with the threat of more to come if China decides to retaliate.
KBH ABX AXL CHK ABG ABX

5
The Housing Market: A Bigger Bubble Than 2008 Is Popping

2018-07-03 seekingalpha
The XHB homebuilder ETF is decisively below three key moving averages after it knifed below its 50-dma last week. KB Home (NYSE:KBH) reported a big earnings and revenue "beat" on Thursday after the market closed. The stock soared as much as 9% on Friday. Per the advice I gave my subscribers about shorting the inevitable price spike in the stock, I shorted the stock Friday mid-day (July and August at-the-money puts).
KBH

1
KB Home (KBH) Jumps: Stock Rises 7.3%

2018-07-02 zacks
KB Home (KBH - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $24.86–$28.33 in the past one-month time frame, witnessed a sharp increase on Friday.
KBH MDC

82
Wall Street ekes out gain as Nike surges

2018-07-01 theedgemarkets
NEW YORK (July 2): Wall Street's major stock indexes edged higher on Friday, as a surge in Nike Inc shares helped the quarter close out on an upswing while concerns over U.S. international trade relations ebbed.
STZ.B VRTX GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS GLSSP NKE MS JBK KBH GSC GS.PRICL TFG PHM GLPG STZ GSJ GS.PRJ GS.PRI MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN GS.PRK

0
KB Home Delivers a Second-Quarter Beat

2018-06-30 investorplace
It’s been a bumpy year for home-building company KB Home (NYSE:KBH), but the firm’s second quarter results showed that things are looking up for the developer’s future. The firm reported EPS of 57 cents per share on revenue of $1.1 billion compared to estimates of 48 cents per share on revenue of $1.043 billion on Thursday after the bell.
KBH

82
Wall Street ekes out gain as Nike surges

2018-06-30 moneycontrol
Wall Street's major stock indexes edged higher on Friday, as a surge in Nike Inc shares helped the quarter close out on an upswing while concerns over US international trade relations ebbed.
STZ.B VRTX GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS GLSSP NKE MS JBK KBH GSC GS.PRICL TFG PHM GLPG STZ GSJ GS.PRJ GS.PRI MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN GS.PRK

82
Wall Street ekes out gain as Nike surges

2018-06-30 malaymail
NEW YORK, June 30 — Wall Street’s major stock indexes edged higher yesterday, as a surge in Nike Inc shares helped the quarter close out on an upswing while concerns over US international trade relations ebbed.
STZ.B VRTX GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS GLSSP NKE MS JBK KBH GSC GS.PRICL TFG PHM GLPG STZ GSJ GS.PRJ GS.PRI MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN GS.PRK

128
US STOCKS-Nike and banks propel Wall Street gains

2018-06-29 reuters
* Indexes up: Dow 0.9 pct, S&P 0.7 pct, Nasdaq 0.6 pct (Updates to late afternoon, changes byline, adds NEW YORK to dateline)
WFCNP STZ.B VRTX C.WSA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ NKE WFC.PRP WFC.PRO WFC.PRN C.WS.A STI-A C.PRP STI.PRE C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS STI.WS.B KBH STI.WS.A C C.PRL C.PRJ C.PRK PHM GLPG STZ C.PRG C.PRC STI C.PRPCL CGBBW

1
Homebuilders Are In Bear Market Territory Ignoring Favorable Housing Market Data

2018-06-29 seekingalpha
D. R. Horton and Lennar set all-time intraday highs in January and are now in bear market territory.
KBH TOL LEN PHM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to KBH / KB Home on message board site Silicon Investor.

KBH Applications KBH: Kaufman u0026 Broad Home Corp
KBH - Kaufman u0026 Broad Home
CUSIP: 48666K109